Previous 10 | Next 10 |
Accolade Launches Medication Integrated Care to Address Prescription Drug Costs and Complications PR Newswire Medication Integrated Care combines pharmacist-led medication therapy management with advanced analytics powered by Rx Savings Solutions to help employers reac...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips One of the most impressive five-day charts in the market right now belongs to Accolade (NADSAQ: ACCD ). After falling approximately 50% in Friday’s session, shares of ACCD stock have rebounded in dramatic fashi...
Following a sharp selloff triggered by a disappointing outlook last week, the shares of Accolade (NASDAQ:ACCD) have bounced back on Monday after Wells Fargo upgraded the health services firm to Equal Weight from Underweight, citing a balanced risk/reward setup. With the earnings, Accolade (AC...
Gainers: Redbox Entertainment (RDBX) +48%. Blue Apron Holdings (APRN) +36%. Accolade (ACCD) +28%. Forge Global Holdings (FRGE) +22%. Hilltop Holdings (HTH) +19%. The Oncology Institute (TOI) +18%. OppFi (OPFI) +18%. Seer (SEER) +16%. Companhia Energetica de Minas Gerais (CIG) +16%. Silk Road ...
Stocks plunged on Friday, hurt by a negative reaction to the latest round of tech earnings, with Amazon posting its biggest single-day loss in more than 15 years. The Nasdaq led the decline, falling 4.2% and recording its worst monthly performance since the Financial Crisis. Even amid a wash ...
The following slide deck was published by Accolade, Inc. in conjunction with their 2022 Q4 earnings call. For further details see: Accolade, Inc. 2022 Q4 - Results - Earnings Call Presentation
Gainers: GTY Technology Holdings (GTYH) +114%. Vaxxinity (VAXX) +57%. Zymeworks (ZYME) +35%. Redbox Entertainment (RDBX) +33%. Finch Therapeutics Group (FNCH) +29%. Opiant Pharmaceuticals (OPNT) +29%. Puyi (PUYI) +27%. Cyngn (CYN) +24%. Clearwater (CLW) +24%. Anixa Biosciences (ANIX) +21%. Lo...
Gainers: Finch Therapeutics (FNCH) +46%. Zymeworks (ZYME) +44%. Lantheus (LNTH) +13%. BeiGene (BGNE) +12%. Inari Medical (NARI) +11%. Losers: Accolade (ACCD) -55%. Aldeyra Therapeutics (ALDX) -15%. Venus Concept (VERO) -14%. Bio...
Accolade (ACCD) -41% on Q4 earnings release. Sono Group (SEV) -12% on pricing $10M follow-on share offering. Robinhood Markets (HOOD) -10% on Q1 earnings release. Amazon.com (AMZN) -10% on Q1 earnings release. The Western Union (WU) -9% o...
Image source: The Motley Fool. Accolade, Inc. (NASDAQ: ACCD) Q4 2022 Earnings Call Apr 28, 2022 , 4:30 p.m. ET Operator Continue reading For further details see: Accolade, Inc. (ACCD) Q4 2022 Earnings Call Transcript
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, NY / ACCESSWIRE / July 15, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD). Investors who purchased Accolade securities are encouraged to obtain additional information ...
NEW YORK, NY / ACCESSWIRE / July 11, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD). Investors who purchased Accolade securities are encouraged to obtain additional information ...
A look at the top 10 most actives in the United States Innovative Eyewear Inc. (LUCY) rose 50.0% to $0.495 on volume of 360,218,139 shares NVIDIA Corporation (NVDA) fell 0.4% to $123.54 on volume of 307,578,749 shares Ginkgo Bioworks Holdings Inc. Class A (DNA) rose 8.1% to $0.3343 on vol...